𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma

✍ Scribed by Tony S. K. Mok; Thomas W. T. Leung; Shou-Dong Lee; Yee Chao; Anthony T. C. Chan; Andrew Huang; Mei-Ching Lui; Winnie Yeo; Karen Chak; Amanda Johnston; Philip Johnson


Publisher
Springer
Year
1999
Tongue
English
Weight
79 KB
Volume
44
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A Phase II trial of nolatrexed dihydroch
✍ Keith Stuart; Judy Tessitore; Jeff Rudy; Neil Clendennin; Amanda Johnston πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

## BACKGROUND. Inoperable hepatocellular carcinoma is an incurable malignancy with no accepted standard therapy. Chemotherapy has demonstrated occasional responses and the need is great for a new and effective agent. Therefore the authors conducted this Phase II trial of a novel thymidylate syntha